JUL 15, 2020 6:38 PM PDT

A Common Drug Could Help Reduce the Risk of COVID-19 Infections

WRITTEN BY: Carmen Leitch

Heparin is a very common drug that's been approved as an anticoagulant since 1992. Researchers have now found that the medication could act as a decoy in SARS-CoV-2 infections; it seems to bind tightly to the spike protein of the pandemic virus, which is what the virus uses to infect cells. If it's given to a person that's been exposed to the virus using a nasal spray or nebulizer, it could lower their risk of infection or potentially lower the likelihood of a severe COVID-19 case. Other decoy drugs have been used to battle viruses like dengue and Zika. The findings have been reported in Antiviral Research.

Colorized scanning electron micrograph of a cell heavily infected with SARS-CoV-2 virus particles (yellow), isolated from a patient sample. The black area in the image is extracellular space between the cells. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: (Modified from) NIAID

"This approach could be used as an early intervention to reduce the infection among people who have tested positive but aren't yet suffering symptoms. But we also see this as part of a larger antiviral strategy," said Robert Linhardt, lead author and a professor of chemistry and chemical biology at Rensselaer Polytechnic Institute. "Ultimately, we want a vaccine, but there are many ways to combat a virus, and as we've seen with HIV, with the right combination of therapies, we can control the disease until a vaccine is found."

When the SARS-CoV-2 virus gets into the body, it has to also enter cells. It does so when its Spike protein attaches to a receptor on human cells called ACE2. In this work, the researchers hypothesized that heparin could also be an attractive binding target for the virus, and could lower the likelihood that it will infect human cells.

When quantified, the link between SARS-CoV-2 and heparin was found to have a binding strength of 73 picomoles.

"That's exceptional, extremely tight binding," explained Jonathan Dordick, a chemical and biological engineering professor at Rensselaer. "It's hundreds of thousands of times tighter than a typical antibody-antigen. Once it binds, it's not going to come off."

Linhardt has been recognized for developing synthetic heparin. While assessing sequencing data for SARS-CoV-2, he and his team saw there were certain sequences that indicated the presence of binding motifs that tend to link to heparin. The researchers investigated how the virus bound to three variants of heparin, and showed that heparin could be an attractive decoy target for the virus. The team is now working to test their theory in a cell culture model.

"This isn't the only virus that we're going to confront in a pandemic," Dordick said. "We don't really have great antivirals, but this is a pathway forward. We need to be in a position where we understand how things like heparin and related compounds can block virus entry."

Sources: AAAS/Eurekalert! via Rensselaer Polytechnic Institute, Antiviral Research

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAY 04, 2021
Immunology
One Vaccine to Rule Them All
MAY 04, 2021
One Vaccine to Rule Them All
There are currently five variants of concern in the U.S., genetically distinct forms of the COVID-causing coronavirus th ...
MAY 06, 2021
Genetics & Genomics
There's More to Viral DNA Than ATGC
MAY 06, 2021
There's More to Viral DNA Than ATGC
Plants and animals have genomes made of four nucleotide bases, adenine (A), thymine (T), cytosine (C), and guanine (G). ...
MAY 10, 2021
Coronavirus
Researchers Create a Vaccine For Multiple SARS Viruses, Including COVID-19 & Variants
MAY 10, 2021
Researchers Create a Vaccine For Multiple SARS Viruses, Including COVID-19 & Variants
The pandemic virus SARS-CoV-2 has changed the world in devastating ways, taking hundreds of thousands of lives & new var ...
MAY 27, 2021
Microbiology
Some Microbes May Protect the Gut From Chemo's Harmful Effects
MAY 27, 2021
Some Microbes May Protect the Gut From Chemo's Harmful Effects
The microbes in our gut can influence our physiology in many ways. Some gut microbes have a positive impact on human hea ...
JUN 06, 2021
Microbiology
Salmonella Outbreaks in North America & the UK
JUN 06, 2021
Salmonella Outbreaks in North America & the UK
The Centers for Disease Control and Prevention (CDC) is warning chicken consumers and people that keep live poultry at h ...
JUL 11, 2021
Drug Discovery & Development
Could Mucus-Based Drugs Replace Antibiotics?
JUL 11, 2021
Could Mucus-Based Drugs Replace Antibiotics?
Researchers from the Copenhagen Center for Glycomics in Denmark have developed a way to produce healthy mucus artificial ...
Loading Comments...